02/14/2025
7:01 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
8:00 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
6:01 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
5:14 PM | Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:01 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:04 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:07 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:10 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:58 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:55 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:58 PM | Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/22/2025
5:00 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:02 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:05 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:07 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:23 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:00 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G | |
11/12/2024
10:53 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
4:34 PM | Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
3:11 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:13 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
10:54 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
5:37 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:41 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:45 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:15 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:22 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
4:01 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:47 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:54 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:41 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:57 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal…
A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology.
It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here. |
06/17/2024
6:52 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2024
6:43 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
3:27 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:02 AM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:45 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:20 PM | Pliant Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
